← FDA Drug Approvals (Drugs@FDA)

ROPIVACAINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ANTHEA PHARMA · Approved 2025-03-21

Drug application

FDA Application #

ANDA219883

Application type

Abbreviated New Drug Application (Generic)

Brand name

ROPIVACAINE HYDROCHLORIDE

Generic name

ROPIVACAINE HYDROCHLORIDE

Active ingredients

ROPIVACAINE HYDROCHLORIDE

Dosage form

SOLUTION

Route

INJECTION

Marketing status

Prescription

Sponsor

ANTHEA PHARMA

Manufacturer

Glenmark Pharmaceuticals Inc., USA

First approval

2025-03-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown